ArticleGynecologic oncology reports2024

Long-term disease-free survival with chemotherapy and pembrolizumab in a patient with unmeasurable, advanced stage dedifferentiated endometrial carcinoma.

Joy M Davis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.